Demand and willingness to pay for human papilloma virus vaccine for their daughters among mothers in Haryana, India: A contingent valuation study
Abstract
Objectives Cervical cancer accounts for 10 percent of cancer deaths among women in India. The human papillomavirus (HPV) vaccine can protect against infection but it is not included in India's universal immunisation programme. This study aimed to assess the demand and willingness to pay for the HPV vaccine among mothers of adolescent daughters. Methods We conducted a contingent valuation exercise involving a hospital-based cross-sectional study to assess the demand for an HPV vaccine among mothers of adolescent daughters, their willingness to pay and its determinants. Participants were recruited at a tertiary care civil hospital in the city of Gurgaon in North India, and data was collected from December 2018 to February 2019. A questionnaire was administered to obtain demographic and awareness indicators. Payment cards were used to elicit the willingness to pay amount. Results Out of 319 respondents, 79% were willing to pay for the vaccine. The mean maximum willingness to pay was INR 629 (USD 35), which was less than the vaccine market price of INR 2000-3000 (USD 117-175) per dose. Participant age and number of children significantly influenced demand, while family income and awareness of cervical cancer influenced willingness to pay for the HPV vaccine. Participants were willing to spend between 3% and 34% of their monthly income on the vaccine. Conclusions High demand and low willingness to pay for the HPV vaccine indicate low value perception of the health outcome among mo…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Interpersonal factors like parental influence, peer support, and healthcare provider recommendations shaped decisions, though outreach was inconsistent in underserved areas.
“Interpersonal factors like parental influence, peer support, and healthcare provider recommendations also shaped decisions, though outreach was inconsistent in underserved areas31,39,45.”
From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [31]
Girls from urban and higher socioeconomic backgrounds were more likely to have heard of HPV and the vaccine, whereas those from rural or tribal areas had lower awareness and greater scepticism.
“Girls from urban and higher socioeconomic backgrounds were more likely to have heard of HPV and the vaccine, whereas those from rural or tribal areas were found to have lower awareness and greater scepticism31,32,36.”
From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [31]
Despite educational interventions, a subset of participants remained hesitant, often citing concerns about vaccine cost, availability, or insufficient information from healthcare providers.
“Despite this, a subset of participants remained hesitant, often citing concerns about vaccine cost, availability, or insufficient information from healthcare providers31,32,38,43.”
From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [31]
Cost is a primary barrier to HPV vaccination in India.
“Cost emerged as a primary barrier.”
From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [31]
High cost per dose of commercially available vaccines like Gardasil and Cervarix makes them unaffordable for most Indian families, particularly in rural and low-income settings.
“Several studies cited the high cost per dose for commercially available vaccines like Gardasil and Cervarix, making them unaffordable for most Indian families, particularly in rural and low-income settings17,21,31.”
From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [31]
Cites
Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts
Sankaranarayanan, R., Basu, P., Kaur, P., Bhaskar, R., Singh, G. B., Denzongpa, P., Grover, R. K., Sebastian, P., Saikia, T., Oswal, K., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30531-5 · Cited by 136 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Barriers to HPV vaccination among adolescent girls in India: A scoping review
Josten, K., Rose Dhar, R., Reshmi, B., Natti Krishna, V., & Vennila, J. (2026) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1834_2025 · Cited by 6 · see citing works
“Several studies cited the high cost per dose for commercially available vaccines like Gardasil and Cervarix, making them unaffordable for most Indian families, particularly in rural and low-income settings 17,21,31 .”
Influential
- Authors
- Ray, S., Mulchandani, R., & Patel, P.
- Affiliations
- Public Health Foundation of India (IN)
- Corresponding author
- Ray, Shomik
- Venue
- Journal of Health Services Research & Policy
- Publisher
- SAGE Publications
- Published
- 2023-11-23
- Volume
- 29
- Issue
- 2
- Pages
- 76-83
- ISSN
- 1355-8196 (ISSN-L)
- 1758-1060
- OpenAlex
- W4388942076
- Cited by
- 8
- References
- 1
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Health Services Research & Policy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- HPV vaccine, willingness to pay, vaccine demand, cervical cancer prevention, adolescent girls, maternal decision-making, vaccine pricing, vaccine subsidies, cervical cancer awareness, Haryana
- MeSH terms
- Adolescent, Uterine Cervical Neoplasms, Child, Cross-Sectional Studies, Female, Humans, India, Health Knowledge, Attitudes, Practice, Nuclear Family, Surveys and Questionnaires, Vaccination, Papillomavirus Infections, Papillomavirus Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review